COMMUNIQUÉS West-GlobeNewswire

OpGen Announces Date of Fourth Quarter and Fiscal Year 2018 Financial Results Conference Call
20/02/2019
GAITHERSBURG, Md., Feb. 20, 2019 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ: OPGN) announced today that the Company will report its fourth quarter and fiscal year 2018 financial results after the close of the U.S. [...]
Cytokinetics Announces Initiation of Phase 1 Clinical Study of AMG 594, a Cardiac Troponin Activator
20/02/2019
Advancement of Second Novel Mechanism Cardiac Sarcomere Activator Reinforces Leadership Position in Muscle Directed Pharmacology SOUTH SAN FRANCISCO, Calif., Feb. 20, 2019 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated [...]
CV Sciences’ PlusCBD Oil™ Gold Softgels Named “Top Pick” by ConsumerLab.com
20/02/2019
Country’s top-selling hemp-derived CBD brand recognized for its purity and value; PlusCBD Oil™ products pass rigorous third-party quality testing for THC and heavy metals LAS VEGAS, Feb. 20, 2019 (GLOBE NEWSWIRE) -- CV [...]
Vericel to Participate in Multiple Upcoming Investor Conferences
20/02/2019
CAMBRIDGE, Mass., Feb. 20, 2019 (GLOBE NEWSWIRE) -- Vericel Corporation (NASDAQ:VCEL), a leader in advanced cell therapies for the sports medicine and severe burn care markets, today announced participation in multiple [...]
Mustang Bio and Nationwide Children’s Hospital Enter into Exclusive Worldwide License Agreement for Oncolytic Virus (C134) to Treat Glioblastoma Multiforme
20/02/2019
Phase 1 trial underway at the University of Alabama at Birmingham in recurrent glioblastoma multiforme Mustang intends to combine the oncolytic virus (C134) with MB-101 (IL13Rα2-specific CAR) to potentially enhance [...]
ChemoCentryx to Present at the 8th Annual SVB Leerink Global Healthcare Conference
20/02/2019
MOUNTAIN VIEW, Calif., Feb. 20, 2019 (GLOBE NEWSWIRE) -- ChemoCentryx, Inc., (Nasdaq: CCXI), today announced that Thomas J. Schall, Ph.D., President and Chief Executive Officer, will present at the 8th Annual SVB [...]
Uptick Newswire Hosts Premier Biomedical, Inc. on The Stock Day Podcast to Discuss the Company’s Current Projects
20/02/2019
PHOENIX, Feb. 20, 2019 (GLOBE NEWSWIRE) -- Uptick Newswire Stock Day Podcast welcomed Premier Biomedical, Inc. (BIEI), a research-based publicly traded company that intends to discover and develop medical treatments for [...]
Organovo Appoints New Board Member
20/02/2019
SAN DIEGO, Feb. 20, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”), a biotechnology company pioneering the development of 3D bioprinted tissues aimed at treating a range of serious adult and [...]
Sienna Biopharmaceuticals Prices Public Offering of Common Stock
20/02/2019
WESTLAKE VILLAGE, Calif., Feb. 20, 2019 (GLOBE NEWSWIRE) -- Sienna Biopharmaceuticals, Inc. (Nasdaq:SNNA), a clinical-stage biopharmaceutical company, today announced the pricing of an underwritten public offering of 8, [...]
Milestone Scientific Provides Update on CompuFlo® Epidural System Commercial Launch
20/02/2019
Four published studies validate instrument effectiveness in identifying epidural space More than 1,500 epidural procedures performed by key opinion leaders First hospital in Italy adopts CompuFlo for all epidurals in [...]
CareDx Drives Personalized Medicine in Transplantation at CEOT
20/02/2019
AlloSure highlighted at Cutting Edge in Transplantation conference in multiple sessions BRISBANE, Calif., Feb. 20, 2019 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a molecular diagnostics company focused on the [...]
miRagen Therapeutics to Report Fourth Quarter and Fiscal 2018 Financial Results and Host a Conference Call on March 13th
20/02/2019
BOULDER, Colo., Feb. 20, 2019 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ: MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, will host a [...]
Zogenix to Present at the 8th Annual SVB Leerink Global Healthcare Conference
20/02/2019
EMERYVILLE, Calif., Feb. 20, 2019 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ: ZGNX), a global pharmaceutical company developing rare disease therapies, today announced that Stephen J. Farr, President and CEO, will [...]
Mersana Therapeutics to Present at the 8th Annual SVB Leerink Global Healthcare Conference
20/02/2019
CAMBRIDGE, Mass., Feb. 20, 2019 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc., (NASDAQ:MRSN) a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug conjugates (ADCs [...]
VBL Therapeutics Awarded $2.9 Million Non-Dilutive Grant by the Israel Innovation Authority
20/02/2019
TEL AVIV, Israel, Feb. 20, 2019 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT) (the “Company”) today announced that it has been awarded a non-dilutive grant of over 10 million New Israeli Shekels (approximately $2. [...]
Intra-Cellular Therapies to Host Fourth Quarter and Full Year 2018 Financial Results Conference Call and Webcast
20/02/2019
NEW YORK, Feb. 20, 2019 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today [...]
HTG Molecular to Present Corporate Overview at the 8th Annual SVB Leerink Global Healthcare Conference
20/02/2019
TUCSON, Ariz., Feb. 20, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that TJ Johnson, Chief [...]
Principia Biopharma to Present at 8th Annual SVB Leerink Global Healthcare Conference
20/02/2019
SOUTH SAN FRANCISCO, Calif., Feb. 20, 2019 (GLOBE NEWSWIRE) -- Principia Biopharma Inc. (Nasdaq: PRNB), a late-stage biopharmaceutical company dedicated to bringing transformative oral therapies to patients with [...]
CymaBay Therapeutics to Present at the 8th Annual SVB Leerink Global Healthcare Conference
20/02/2019
NEWARK, Calif., Feb. 20, 2019 (GLOBE NEWSWIRE) -- CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a clinical-stage biopharmaceutical company focused on developing therapies for liver and other chronic diseases with high [...]

Pages